Success Stories: Our Team’s Effort Makes NIW Approval Possible for an Associate Research Scientist from China Working in the Field of Biostatistics

 

Client’s Testimonial:

“It has been a pleasure working with you and thanks for all of your help!”


On April 5th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Biostatistics (Approval Notice).


General Field: Biostatistics

Position at the Time of Case Filing: Associate Research Scientist

Country of Origin: China

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: April 5th, 2022

Processing Time: 12 month, 7 days


Case Summary:

The I-140 NIW or National Interest Waiver client is one of the many immigrant visa types for foreign individuals who can prove that their work is of importance to the United States. This is where NAILG comes in. We help our clients obtain NIW status by building them a solid petition using the following:

  • Updated CVs
  • Transcripts from universities and other academic institutions
  • Certificates of recognition from academic and professional institutions
  • Letters of recommendation from other experts
  • Funding information
  • Information regarding publications and citations
As such, when we received a client from China seeking help with her NIW case, we looked into her documents and found the following for her petition letter:
  • As an expert in the field of biostatistics, her proposed endeavor is to develop and apply novel statistical methodologies to more accurately evaluate healthcare data, improve the efficacy of treatments, and accurately characterize the mechanisms for conditions such as cancer, and COVID-19.
  • Her work advancing her proposed endeavor is of great importance because it directly relates to efforts to improve understanding and treatment strategies for some of the most prevalent and deadly diseases around the world.
  • Due to its clear national importance, her research has in fact been supported with funding from different sources.
  • She has completed at least 22 reviews to date for international scientific journals of repute.
  • Her research has resulted in 27 peer-reviewed journal articles published and read across the world.
  • These publications have been cited a total of 131 times according to Google Scholar, showing clearly the major impact of her original contributions in the field of biostatistics.
  • She has also received 4 letters of recommendation from experts in her field, two of which said the following:
“Improving the safety of PCI procedures substantially lowers cardiovascular deaths in the US. Similarly, cancer is the second leading cause of death for Americans according to the CDC. It is clear that [the client’s] research is crucial for addressing gaps in US medical knowledge, and she is well positioned to fill those gaps with her continued work.”

“[The client’s] research is particularly relevant to the U.S. because her applications of biostatistics improve biomedical understanding of disease prognosis and the health data of large populations. Her current work focuses on COVID-19, which is of considerable importance within the U.S. as the nation is currently experiencing a major surge in cases. Her research highlights areas of improvement to make preventive measures more accessible to at-risk populations. For these reasons, [the client’s] work is within U.S. medical interests, and her important work must continue unimpeded.”

Thus, our team successfully showed that the client is uniquely well positioned to pursue this work considering the breadth of her many years of experience as well as her leadership and expertise in the field. This won her the NIW approval without an RFE, of which we are proud. We thank our client for her patience and trust. Our firm wishes her the very best in all future endeavors.